Harbeck N - Search Results

1

Advanced Breast Cancer: AGO Recommendations 2022 - Focus on ABC6 Consensus.

Untch M, Fasching PA, Haidinger R, Harbeck N, Jackisch C, Lüftner D, Müller V, Schumacher-Wulf E, Würstlein R, Thomssen C. Untch M, et al. Among authors: harbeck n. Geburtshilfe Frauenheilkd. 2022 Sep 30;82(10):1044-1054. doi: 10.1055/a-1904-6100. eCollection 2022 Oct. Geburtshilfe Frauenheilkd. 2022. PMID: 36186150 Free PMC article.

2

[Possibilities in immunocytochemistry exemplified by bone marrow aspiration cytology in patients with breast carcinoma].

Eiermann W, Harbeck N, Untch M. Eiermann W, et al. Among authors: harbeck n. Gynakologe. 1990 Dec;23(6):358-64. Gynakologe. 1990. PMID: 2177719 German. No abstract available.

3

Micrometastases in bone marrow in patients with breast cancer.

Untch M, Harbeck N, Eiermann W. Untch M, et al. Among authors: harbeck n. Br Med J (Clin Res Ed). 1988 Jan 23;296(6617):290. doi: 10.1136/bmj.296.6617.290. Br Med J (Clin Res Ed). 1988. PMID: 3124916 Free PMC article. No abstract available.

4

Tumour cell detection in the bone marrow of breast cancer patients at primary therapy: results of a 3-year median follow-up.

Harbeck N, Untch M, Pache L, Eiermann W. Harbeck N, et al. Br J Cancer. 1994 Mar;69(3):566-71. doi: 10.1038/bjc.1994.103. Br J Cancer. 1994. PMID: 7510120 Free PMC article.

5

Clinical utility of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 determination in primary breast cancer tissue for individualized therapy concepts.

Harbeck N, Schmitt M, Kates RE, Kiechle M, Zemzoum I, Jänicke F, Thomssen C. Harbeck N, et al. Clin Breast Cancer. 2002 Aug;3(3):196-200. doi: 10.3816/CBC.2002.n.023. Clin Breast Cancer. 2002. PMID: 12196277 Review.

6

Detection and clinical implications of early systemic tumor cell dissemination in breast cancer.

Pantel K, Müller V, Auer M, Nusser N, Harbeck N, Braun S. Pantel K, et al. Among authors: harbeck n. Clin Cancer Res. 2003 Dec 15;9(17):6326-34. Clin Cancer Res. 2003. PMID: 14695131

7

The patient experience.

Harbeck N, Haidinger R. Harbeck N, et al. Breast Cancer Res Treat. 2007;105 Suppl 1(Suppl 1):91-103. doi: 10.1007/s10549-007-9703-8. Epub 2007 Oct 3. Breast Cancer Res Treat. 2007. PMID: 17912639 Free PMC article. Review.

8

Monitoring primary systemic therapy of large and locally advanced breast cancer by using sequential positron emission tomography imaging with [18F]fluorodeoxyglucose.

Schwarz-Dose J, Untch M, Tiling R, Sassen S, Mahner S, Kahlert S, Harbeck N, Lebeau A, Brenner W, Schwaiger M, Jaenicke F, Avril N. Schwarz-Dose J, et al. Among authors: harbeck n. J Clin Oncol. 2009 Feb 1;27(4):535-41. doi: 10.1200/JCO.2008.17.2650. Epub 2008 Dec 15. J Clin Oncol. 2009. PMID: 19075273

9

Intensive dose-dense compared with conventionally scheduled preoperative chemotherapy for high-risk primary breast cancer.

Untch M, Möbus V, Kuhn W, Muck BR, Thomssen C, Bauerfeind I, Harbeck N, Werner C, Lebeau A, Schneeweiss A, Kahlert S, von Koch F, Petry KU, Wallwiener D, Kreienberg R, Albert US, Lück HJ, Hinke A, Jänicke F, Konecny GE. Untch M, et al. Among authors: harbeck n. J Clin Oncol. 2009 Jun 20;27(18):2938-45. doi: 10.1200/JCO.2008.20.3133. Epub 2009 Apr 13. J Clin Oncol. 2009. PMID: 19364964 Clinical Trial.

10

Association between HER2, TOP2A, and response to anthracycline-based preoperative chemotherapy in high-risk primary breast cancer.

Konecny GE, Pauletti G, Untch M, Wang HJ, Möbus V, Kuhn W, Thomssen C, Harbeck N, Wang L, Apple S, Jänicke F, Slamon DJ. Konecny GE, et al. Among authors: harbeck n. Breast Cancer Res Treat. 2010 Apr;120(2):481-9. doi: 10.1007/s10549-010-0744-z. Epub 2010 Feb 4. Breast Cancer Res Treat. 2010. PMID: 20130985

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

691 results

Search Page